Therapeutic effect of recombinant human erythropoietin on anaemia with erythropoietin deficiency in diabetic patients

Diabetic Medicine

Volumn 20, Issue 8, 2003, Pages 661-664

  Kim, D J ^a   Kim, Y M ^b   Yun, Y S ^b   Ahn, C W ^b   Cha, B S ^b   Song, Y D ^a   Lim, S K ^b   Kim, K R ^b   Hahnt, J S ^b   Huh, K B ^b   Lee, Hyun Chul ^b  

^a National Health Insurance Corporation   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Anaemia; Diabetic nephropathy; Erythropoietin; Recombinant erythropoietin

Indexed keywords

ALBUMIN; CREATININE; EPOKINE; ERYTHROPOIETIN; FERRITIN; HEMOGLOBIN; HEMOGLOBIN A1C; IRON; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN;

ADULT; ANEMIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVULSION; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DISEASE DURATION; DRUG EFFECT; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; HYPERTENSION; IRON BLOOD LEVEL; KIDNEY FAILURE; MALE; METAL BINDING; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; PROTEIN URINE LEVEL; QUANTITATIVE ANALYSIS; SIDE EFFECT; URINARY EXCRETION;

ANEMIA; DIABETES COMPLICATIONS; ERYTHROPOIETIN; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 0042134554     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2003.01012.x     Document Type: Article

References (14)

1. Robert LJ, Charles MP. Hematologic alterations in diabetes mellitus. Am J Med 1981; 70: 339-352.
2. Peterson CM, Jones RL, Koenig RJ, Melvin ET, Lehrman ML. Reversible hematologic sequelae of diabetes mellitus. Ann Intern Med 1977; 86: 425-429.
3. Kojima K, Totsuka Y. Anemia due to reduced serum erythropoietin concentration in non-uremic diabetic patients. Diabetes Res Clin Pract 1995; 27: 229-233.
4. Rarick MU, Espina BM, Colley DT, Chrusoskie A, Gandara S, Feinstein DI. Treatment of a unique anemia in patients with IDDM with Epoetin alfa. Diabetes Care 1998; 21: 423-426.
5. Winkler AS, Marsden J, Chaudhuri KR, Hambley H, Watkins PJ. Erythropoietin depletion and anaemia in diabetes mellitus. Diabet Med 1999; 16: 813-819.
6. Ricerca BM, Todaro L, Caputo S, Cotroneo P, Damiani P, Manto A et al. Blunted erythropoietin response to anemia in type 1 diabetic patients, Diabetes Care 1999; 22: 647 (Letter).
7. Bosman DR, Winkler AS, Marsden JT, Macdougall IC, Watkins PJ. Anemia with erythropoietin deficiency occurs early in diabetic nephropathy. Diabetes Care 2001; 24: 495-499.
8. Yun YS, Lee HC, Yoo NC, Song YD, Lim SK, Kim KR et al. Reduced erythropoietin responsiveness to anemia in diabetic patients before advanced diabetic nephropathy. Diabetes Res Clin Pract 1999; 46: 223-229.
9. Eschbach JW, Kelly MR, Haley NR, Abels RI, Adamson JW. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. N Engl J Med 1989; 321: 158-163.
10. Lim VS, DeGowin RL, Zavala D, Kirchner PT, Abels R, Perry R et al. Recombinant human erythropoietin treatment in pre-dialysis patients. A double-blind placebo-controlled trial. Ann Intern Med 1989; 110: 108-114.
11. Fischl M, Galpin JE, Levine JD, Groopman JE, Henry DH, Kennedy P et al. Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med 1990; 322: 1488-1493.
12. Case DC, Bukowski RM, Carey RW, Fishkin EH, Henry DH, Jacobson RJ et al. Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy. J Natl Cancer Inst 1993; 85: 801-806.
13. Ratke HW, Claussner A, Erbes PM, Scheuermann EH, Scheppe W, Koch KM. Serum erythropoietin concentration in chronic renal failure: relationship to degree of anemia and excretory renal function. Blood 1979; 54: 877-884.
14. Cazzola M, Mercuriali F, Brugnara C. Use of recombinant human erythropoietin outside the setting of uremia. Blood 1997; 89: 4248-4267.